Children’s Calcium ± Vitamin D Dietary Supplements (DS): Nutrient Strength and Compliance with FDA Guidance for Performance Quality and Labeling of Chewable Tablets

Children’s Calcium ± Vitamin D Dietary Supplements (DS): Nutrient Strength and Compliance with FDA Guidance for Performance Quality and Labeling of Chewable Tablets

Saved in:

Bibliographic Details
Main Authors:	Pavel Gusev, Karen Andrews Andrews, Josiah Ekong, Deepesh Pandey, Laura Oh, Suma Vavilala, Pamela Pehrsson, Johanna Dwyer, Rebecca Costello, Adam Kuszak, Larry Douglass
Format:	Article
Language:	English
Published:	Elsevier 2025-05-01
Series:	Current Developments in Nutrition
Online Access:	http://www.sciencedirect.com/science/article/pii/S2475299125022796
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

5-methyltetrahydrofolate (5-MTHF) in Dietary Supplements (DS): Isomer Composition and Dosage Form Performance at the Initial Shelf-life
by: Deepesh Pandey, et al.
Published: (2025-05-01)

Pharmaceutical Equivalence of Film-Coated and Chewable Tablets: A Comparative Dissolution Study Using Pulverized Chewable Tablets
by: Suck-Yong Park, et al.
Published: (2024-11-01)

Formulation Optimization and Quality Analysis of Dendrobium officinale Chewable Tablets
by: Wenyu ZHANG, et al.
Published: (2025-02-01)

Technological aspects of obtaining the chewable tablets with oats extract and quercetin
by: I. R. Andriichuk, et al.
Published: (2014-12-01)

Safety of Fluralaner Chewable Tablets Bravecto® in Dogs with Dermatitis–Clinical Pathology Parameters Evaluation
by: Adriana AMFIM, et al.
Published: (2025-05-01)

Development of 3D printed dexamethasone chewable tablets for prophylaxis of chemotherapy-induced nausea and vomiting in children
by: Adrin Dadkhah, et al.
Published: (2025-12-01)

Development of 3D-Printed Chewable Gummy Tablets with Adjustable Ondansetron Content for the Treatment of Pediatric Patients
by: Martin Veselý, et al.
Published: (2025-04-01)

Development of raft-forming liquid and chewable tablet formulations incorporating quercetin solid dispersions for treatment of gastric ulcers
by: Suputra Bunlung, et al.
Published: (2021-10-01)

3D Printing of chewable oral tablets using drug nanosuspension inks: an experimental and machine learning study
by: Hang Truong, et al.
Published: (2025-12-01)

Safety of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) in dogs infected with adult heartworms (Dirofilaria immitis)
by: Kari L. Riggs, et al.
Published: (2025-04-01)

Efficacy of a novel chewable tablet (Credelio Quattro™) containing lotilaner, moxidectin, praziquantel, and pyrantel for the treatment and control of hookworm infections in dogs
by: Samuel Charles, et al.
Published: (2025-04-01)

Towards a Customized Oral Drug Therapy for Pediatric Applications: Chewable Propranolol Gel Tablets Printed by an Automated Extrusion-Based Material Deposition Method
by: Kristiine Roostar, et al.
Published: (2025-07-01)

Efficacy of a novel chewable tablet (Credelio Quattro™) containing lotilaner, moxidectin, praziquantel, and pyrantel against Toxocara canis and Toxascaris leonina infections in dogs
by: Samuel Charles, et al.
Published: (2025-08-01)

Efficacy of a novel chewable tablet (Credelio Quattro™) containing lotilaner, moxidectin, praziquantel, and pyrantel for the treatment and control of Echinococcus multilocularis and E. granulosus infections in dogs
by: Samuel Charles, et al.
Published: (2025-03-01)

Erosive potential of children’s chewable vitamin supplements: An in vitro investigation
by: Wannee Lertsooksawat, et al.
Published: (2024-12-01)

Field efficacy and safety evaluation of a novel chewable tablet (Credelio Quattro™) containing lotilaner, moxidectin, praziquantel, and pyrantel against gastrointestinal nematode infections in dogs in the USA
by: Samuel Charles, et al.
Published: (2025-07-01)

Formulation of New Chewable Oral Dosage Forms of Meclizine and Pyridoxine Hydrochloride
by: Wafa M. Al-Madhagi, et al.
Published: (2023-01-01)

FDA position statement “Early Alzheimer's disease: Developing drugs for treatment, Guidance for Industry”
by: Marwan N. Sabbagh, et al.
Published: (2019-01-01)

Impact of non‐binding FDA guidances on primary endpoint selection in Alzheimer's disease trials
by: Jeffrey C. Yu, et al.
Published: (2022-01-01)

Three-Dimensional-Printed Isoniazid Chewable Gels for On-Demand Latent Tuberculosis Treatment in Children
by: Amanda de O. E. Moreira, et al.
Published: (2025-05-01)

51 Improving compliance to neutropenic sepsis guidance for haematology and oncology patients
by: Amy Dalziel, et al.
Published: (2025-03-01)

Using the FDA’s Fish and Fishery Products Hazards and Controls Guidance to Develop HACCP Plans for Fish and Fisheries Products
by: Razieh Farzad
Published: (2025-02-01)

THE RELATIONSHIP OF COMPLIANCE IN CONSUMING FE TABLETS AND THE INCIDENT OF ANEMIA IN PREGNANT WOMEN IN THE TRIMESTER III
by: Veryudha Eka Prameswari
Published: (2024-08-01)

Study on classification of aluminum plastic packaging tablets for drugs based on SOM-FDA using XRF spectroscopy(基于SOM-FDA利用XRF对药品铝塑包装片的分类)
by: 姜红(JIANG Hong), et al.
Published: (2024-11-01)

Impact of stakeholder cooperation for centralized route guidance and full automated vehicle compliance
by: Simeon Calvert, et al.
Published: (2025-04-01)

Photometric Compliance of Tablet Screens and Retro-Illuminated Acuity Charts As Visual Acuity Measurement Devices.
by: I A T Livingstone, et al.
Published: (2016-01-01)

Compliance of Iron Tablet Consumption and Anemia in Third Trimester of Pregnancy at Sleman Primary Health Care, Yogyakarta
by: Linda Yunika, et al.
Published: (2025-02-01)

Formula Labelling in the United Kingdom: Manufacturers' Compliance With the Code, UK Law and Guidance Notes
by: Maiko Kamata, et al.
Published: (2025-04-01)

Cybersecurity requirements for medical devices in the EU and US - A comparison and gap analysis of the MDCG 2019–16 and FDA premarket cybersecurity guidance
by: Max Ostermann, et al.
Published: (2025-01-01)

Urban Lifewor(l)ds
by: Hanna Musiol
Published: (2024-09-01)

Aspects of dS/CFT holography
by: Indranil Dey, et al.
Published: (2025-05-01)

Optimizing dsRNA sequences for RNAi in pest control and research with the dsRIP web platform
by: Doga Cedden, et al.
Published: (2025-04-01)

Grandparents Raising Grandchildren: Guidance and Discipline
by: Millie Ferrer-Chancy, et al.
Published: (2009-10-01)

Assessment of Knowledge Regarding Anemia and Compliance to Iron and Folic Acid Tablets among Pregnant Females at Primary Health Center in Haryana
by: Neha Dhingra, et al.
Published: (2024-07-01)

Ceftobiprole versus ceftriaxone ± linezolid in Community-Acquired Bacterial Pneumonia (CABP): Re-analysis of a randomized, phase 3 study using 2020 FDA guidance
by: Andrew F. Shorr, et al.
Published: (2025-01-01)

Ceftobiprole versus ceftriaxone ± linezolid in Community-Acquired Bacterial Pneumonia (CABP): Re-analysis of a randomized, phase 3 study using 2020 FDA guidance.
by: Andrew F Shorr, et al.
Published: (2025-01-01)

The introduction and inspiration from US FDA guidance: bacterial risk control strategies for blood collection establishments and transfusion services to enhance the safety and availability of platelets for transfusion
by: ZHANG Ningjie, et al.
Published: (2025-01-01)

The afterwor(l)ds of Édouard Glissant
by: Oana Panaïté
Published: (2022-06-01)

A microscopic realization of dS$_3$
by: Scott Collier, Lorenz Eberhardt, Beatrix Mühlmann
Published: (2025-04-01)

Relationship Of Family Knowledge And Support With Pregnant Women's Compliance In Consuming Fe Tablets In The Working Area Of Publich Health Center Poleang Utara
by: Yulli Fety, et al.
Published: (2024-11-01)